cookies-img
We use third-party cookies to provide support. By continuing to browse this website, you accept our privacy policy.
close-icon
Acumen Pharmaceuticals Inc
3 own
6 watching
Current Price
$3.22
$-0.32
(-9.04%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Market Capitalization
Market Capitalization
199.79M
52-Week High
52-Week High
7.62000
52-Week Low
52-Week Low
1.81000
Average Volume
Average Volume
0.4M
Dividend Yield
Dividend Yield
--
P/E Ratio
P/E Ratio
--
iconMarket Capitalization199.79M
icon52-Week High7.62000
icon52-Week Low1.81000
iconAverage Volume0.4M
iconDividend Yield--
iconP/E Ratio--
What does the Acumen Pharmaceuticals Inc do?
Acumen Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapies for the treatment of Alzheimer s disease. The company focuses on advancing a targeted immunotherapy drug candidate ACU193, a humanized monoclonal antibody that is in Phase I clinical-stage to target soluble amyloid-beta oligomers. Acumen Pharmaceuticals, Inc. was incorporated in 1996 and is headquartered in Charlottesville, Virginia.
Read More
How much money does Acumen Pharmaceuticals Inc make?
News & Events about Acumen Pharmaceuticals Inc.
TipRanks Financial Blog
1 year ago
In a report released yesterday, Thomas Shrader from BTIG maintained a Buy rating on Acumen Pharmaceuticals (ABOS Research Report), with a price t... In a report released yesterday, Thomas Shrader from BTIG maintained a Buy rating on Acumen Pharmaceuticals (ABOS &#8211...
Zolmax
1 year ago
Acumen Pharmaceuticals (NASDAQ:ABOS Get Rating) and Elevation Oncology (NASDAQ:ELEV Get Rating) are both small-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their dividends, earnings, analyst recommendations, risk, profitability, ...
Globe Newswire
1 year ago
Topline results including safety and proof-of-mechanism data expected in third quarter of 2023CHARLOTTESVILLE, Va. and CARMEL, Ind., Feb. 13, 2023 (GLOBE NEWSWIRE) -- Acumen Pharmaceuticals, Inc. (NASDAQ: ABOS) (Acumen or the Company), a clinical-stage biopharmaceutical company developing a novel ...
Zolmax
1 year ago
HC Wainwright restated their buy rating on shares of Acumen Pharmaceuticals (NASDAQ:ABOS Get Rating) in a report released on Thursday morning, Benzinga reports. HC Wainwright currently has a $15.00 price target on the stock. ABOS has been the subject of a number of other research reports. ...
Globe Newswire
1 year ago
CHARLOTTESVILLE, Va. and CARMEL, Ind., Jan. 04, 2023 (GLOBE NEWSWIRE) -- Acumen Pharmaceuticals, Inc. (NASDAQ: ABOS) (Acumen or the Company), a clinical-stage biopharmaceutical company focused on the development of novel targeted therapeutics for Alzheimers disease (AD), today announced Derrell ...
Frequently Asked Questions
Frequently Asked Questions
What is Acumen Pharmaceuticals Inc share price today?
plus_minus_icon
Can Indians buy Acumen Pharmaceuticals Inc shares?
plus_minus_icon
How can I buy Acumen Pharmaceuticals Inc shares from India?
plus_minus_icon
Can Fractional shares of Acumen Pharmaceuticals Inc be purchased?
plus_minus_icon
What are the documents required to start investing in Acumen Pharmaceuticals Inc stocks?
plus_minus_icon
What is today’s traded volume of Acumen Pharmaceuticals Inc?
plus_minus_icon
What is today’s market capitalisation of Acumen Pharmaceuticals Inc?
plus_minus_icon
What is the 52-Week High and Low Range of Acumen Pharmaceuticals Inc?
plus_minus_icon
What percentage is Acumen Pharmaceuticals Inc down from its 52-Week High?
plus_minus_icon
What percentage is Acumen Pharmaceuticals Inc up from its 52-Week Low?
plus_minus_icon
Current Price
$3.22
$-0.32
(-9.04%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Get Started with as little as $1.00